A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors

被引:4
作者
Golinelli, Giulia [1 ]
Talami, Rebecca [1 ]
Frabetti, Stella [2 ]
Candini, Olivia [2 ]
Grisendi, Giulia [1 ]
Spano, Carlotta [2 ]
Chiavelli, Chiara [1 ]
Arnaud, Gaelle F. [3 ]
Mari, Giorgio [2 ,3 ]
Dominici, Massimo [1 ,2 ]
机构
[1] Univ Hosp Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Div Oncol, Modena, Italy
[2] Rigenerand Srl, Medolla, Italy
[3] Sci & Technol Pk Med, Tecnopolo Mirandola Mario Veronesi, Mirandola, Italy
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2022年 / 9卷
关键词
ewing's sarcoma; 3D cell cultures; bioreactor; tumor-stroma interaction; mesenchymal stromal; stem cells; ddPCR; fluidic circuit; cancer therapy; STEM-CELLS; EWING SARCOMA; IN-VITRO; CANCER; EXPRESSION; MICROENVIRONMENT; SIMILARITIES; FIBROBLASTS; CROSSTALK; APOPTOSIS;
D O I
10.3389/fcell.2021.767253
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We here investigated the dynamic cell-to-cell interactions between tumor and mesenchymal stromal/stem cells (MSCs) by the novel VITVOCIRCLED LATIN CAPITAL LETTER R 3D bioreactor that was customized to develop in vivo-like metastatic nodules of Ewing's sarcoma (ES). MSCs are known to contribute to tumor microenvironment as cancer associated fibroblast (CAF) precursors and, for this reason, they have also been used as anti-cancer tools. Using dynamic conditions, the process of tissue colonization and formation of metastatic niches was recreated through tumor cell migration aiming to mimic ES development in patients. ES is an aggressive tumor representing the second most common malignant bone cancer in children and young adults. An urgent and unmet need exists for the development of novel treatment strategies to improve the outcomes of metastatic ES. The tumor-tropic ability of MSCs offers an alternative approach, in which these cells can be used as vehicles for the delivery of antitumor molecules, such as the proapoptotic TNF-related apoptosis inducing ligand (TRAIL). However, the therapeutic targeting of metastases remains challenging and the interaction occurring between tumor cells and MSCs has not yet been deeply investigated. Setting up in vitro and in vivo models to study this interaction is a prerequisite for novel approaches where MSCs affinity for tumor is optimized to ultimately increase their therapeutic efficacy. Here, VITVOCIRCLED LATIN CAPITAL LETTER R integrating a customized scaffold with an increased inter-fiber distance (VITVO50) was used to develop a dynamic model where MSCs and tumor nodules were evaluated under flow conditions. Colonization and interaction between cell populations were explored by droplet digital PCR (ddPCR). VITVO50 findings were then applied in vivo. An ES metastatic model was established in NSG mice and biodistribution of TRAIL-expressing MSCs in mice organs affected by metastases was investigated using a 4-plex ddPCR assay. VITVOCIRCLED LATIN CAPITAL LETTER R proved to be an easy handling and versatile bioreactor to develop in vivo-like tumor nodules and investigate dynamic cell-to-cell interactions with MSCs. The proposed fluidic system promises to facilitate the understanding of tumor-stroma interaction for the development of novel tumor targeting strategies, simplifying the analysis of in vivo data, and ultimately accelerating the progress towards the early clinical phase.
引用
收藏
页数:14
相关论文
共 53 条
  • [31] Integrin-TGF-β crosstalk in fibrosis, cancer and wound healing
    Margadant, Coert
    Sonnenberg, Arnoud
    [J]. EMBO REPORTS, 2010, 11 (02) : 97 - 105
  • [32] 3D Fluid-Dynamic Ovarian Cancer Model Resembling Systemic Drug Administration for Efficacy Assay
    Marrella, Alessandra
    Varani, Gabriele
    Aiello, Maurizio
    Vaccari, Ivan
    Vitale, Chiara
    Mojzisek, Martin
    Degrassi, Cristina
    Scaglione, Silvia
    [J]. ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2021, 38 (01) : 82 - 94
  • [33] High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells
    Marx, JC
    Allay, JA
    Persons, DA
    Nooner, SA
    Hargrove, PW
    Kelly, PF
    Vanin, EF
    Horwitz, EM
    [J]. HUMAN GENE THERAPY, 1999, 10 (07) : 1163 - 1173
  • [34] Interaction of MSC with tumor cells
    Melzer, Catharina
    Yang, Yuanyuan
    Hass, Ralf
    [J]. CELL COMMUNICATION AND SIGNALING, 2016, 14
  • [35] Mesenchymal Stem Cells from Mouse Adipose Tissue Stimulate Tumor Growth
    Moskaleva, E. Yu.
    Semochkina, Yu. P.
    Shuvatova, V. G.
    Rodina, A. V.
    Krasheninnikova, A. A.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2019, 167 (01) : 145 - 149
  • [36] Friends or foes - Bipolar effects of the tumour stroma in cancer
    Mueller, MM
    Fusenig, NE
    [J]. NATURE REVIEWS CANCER, 2004, 4 (11) : 839 - 849
  • [37] Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
    Nazha, Bassel
    Inal, Cengiz
    Owonikoko, Taofeek K.
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [38] Concise Review: MSC Adhesion Cascade-Insights into Homing and Transendothelial Migration
    Nitzsche, Franziska
    Muller, Claudia
    Lukomska, Barbara
    Jolkkonen, Jukka
    Deten, Alexander
    Boltze, Johannes
    [J]. STEM CELLS, 2017, 35 (06) : 1446 - 1460
  • [39] Current and Emerging Applications of Droplet Digital PCR in Oncology
    Olmedillas-López S.
    García-Arranz M.
    García-Olmo D.
    [J]. Molecular Diagnosis & Therapy, 2017, 21 (5) : 493 - 510
  • [40] Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences
    Paunescu, Virgil
    Bojin, Florina M.
    Tatu, Calin A.
    Gavriliuc, Oana I.
    Rosca, Adriana
    Gruia, Alexandra T.
    Tanasie, Gabriela
    Bunu, Carmen
    Crisnic, Daniela
    Gherghiceanu, Mihaela
    Tatu, Fabian R.
    Tatu, Carmen S.
    Vermesan, Simona
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2011, 15 (03) : 635 - 646